SPY is an exchange-traded fund (ETF) that aims to replicate the performance of the S&P 500 Index. The S&P 500 Index includes 500 of the largest publicly traded companies in the United States, representing a broad cross-section of the U.S. economy.
Metrics and analysis →MRNA
Moderna is a biotechnology company that focuses on drug discovery and development based on messenger RNA (mRNA) technology.
- Open
- 198.18
- High
- 210.00
- Low
- 191.46
- Prev close
- 199.33
- Volume
- 10M
- Avg vol 10
- 9M
Today · Market closed · opens Mon 9:30 AM
MRNA chart
Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history
Technical analysis
Daily bars · last bar Nov 20, 2026 · close 199.30
Leaning sell. 7 of 18 signals point down against 5 up, carried by trend. Momentum is mostly neutral. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is strong (ADX 27).
Trend
Momentum
Volatility
Volume
Leaning sell. The close is above 9 of 24 averages and below 15. Price is below the short-term averages (5 to 20) and above the long-term ones (50 to 200). SMA 50 is above SMA 200 (207.97 vs 100.44).
| Period | SMA | EMA | WMA | WEMA |
|---|---|---|---|---|
| 5 | 203.50 | 205.71 | 200.87 | 213.81 |
| 10 | 224.07 | 215.17 | 211.99 | 219.70 |
| 20 | 225.47 | 219.65 | 223.95 | 210.03 |
| 50 | 207.97 | 201.37 | 219.38 | 165.43 |
| 100 | 149.51 | 164.82 | 185.57 | 122.22 |
| 200 | 100.44 | 121.06 | 134.24 | 86.05 |
Green: the close is above that average. Red: below it.
From the bar before the last one. Nearest classic support is the pivot at 198.18. Nearest resistance is R1 at 206.37.
| Level | Classic | Fibonacci | Camarilla | Floor | Woodie | DeMark |
|---|---|---|---|---|---|---|
| R3 | 228.66 | 213.42 | 203.52 | 221.61 | 222.93 | — |
| R2 | 213.42 | 207.59 | 202.12 | 213.42 | 214.08 | — |
| R1 | 206.37 | 204.00 | 200.73 | 206.37 | 207.69 | 209.90 |
| Pivot | 198.18 | 198.18 | 198.18 | 198.18 | 198.83 | 199.94 |
| S1 | 191.13 | 192.35 | 197.93 | 191.13 | 192.45 | 194.66 |
| S2 | 182.94 | 188.76 | 196.54 | 182.94 | 183.59 | — |
| S3 | 167.70 | 182.94 | 195.14 | 175.89 | 177.21 | — |
Patterns that formed on the last 5 bars, newest first.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long-legged doji with the body near the middle of the range.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A candle with a short body and short shadows: a quiet bar.
A small loss on little range; weak on its own.
A candle with a long body and short shadows.
Sellers controlled the bar.
A small body with shadows longer than the body on both sides.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
A long-legged doji with the body near the middle of the range.
Neither side won the bar. On its own it says little; after a strong move it warns the move is tiring.
How candlestick references usually rate the pattern. It is not a success rate measured on this ticker. About candle patterns
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 200.07 | 210.00 | 191.46 | 199.30 | 10M | −0.77 |
| Nov 19, 2026 | 196.03 | 205.22 | 189.98 | 199.33 | 8M | +3.30 |
| Nov 18, 2026 | 206.80 | 208.68 | 196.52 | 196.79 | 7M | −10.01 |
| Nov 17, 2026 | 219.85 | 222.43 | 203.84 | 206.80 | 8M | −13.05 |
| Nov 16, 2026 | 216.74 | 220.59 | 212.50 | 215.27 | 7M | −1.47 |
| Nov 13, 2026 | 224.90 | 231.35 | 221.70 | 223.37 | 8M | −1.53 |
| Nov 12, 2026 | 237.88 | 245.37 | 229.69 | 231.35 | 7M | −6.53 |
| Nov 11, 2026 | 252.78 | 254.86 | 243.00 | 248.69 | 8M | −4.09 |
| Nov 10, 2026 | 265.89 | 273.00 | 250.49 | 250.83 | 11M | −15.06 |
| Nov 9, 2026 | 257.86 | 280.80 | 253.33 | 269.00 | 12M | +11.14 |
| Nov 6, 2026 | 245.40 | 267.50 | 237.86 | 254.19 | 16M | +8.79 |
| Nov 5, 2026 | 258.01 | 261.00 | 237.65 | 241.46 | 12M | −16.55 |
| Nov 4, 2026 | 235.00 | 258.72 | 230.21 | 258.38 | 15M | +23.38 |
| Nov 3, 2026 | 222.02 | 235.50 | 220.23 | 228.44 | 10M | +6.42 |
| Nov 2, 2026 | 224.16 | 230.52 | 217.62 | 220.83 | 8M | −3.33 |
| Oct 30, 2026 | 220.53 | 227.81 | 217.22 | 221.72 | 9M | +1.19 |
| Oct 29, 2026 | 216.43 | 225.00 | 215.35 | 222.76 | 11M | +6.33 |
| Oct 28, 2026 | 204.00 | 218.16 | 202.62 | 214.17 | 12M | +10.17 |
| Oct 27, 2026 | 192.23 | 208.87 | 179.53 | 207.97 | 18M | +15.74 |
| Oct 26, 2026 | 186.90 | 203.82 | 181.65 | 198.85 | 17M | +11.95 |
| Oct 23, 2026 | 196.69 | 206.97 | 183.00 | 200.10 | 22M | +3.41 |
| Oct 22, 2026 | 240.13 | 241.26 | 180.80 | 202.63 | 50M | −37.50 |
| Oct 21, 2026 | 242.20 | 254.48 | 239.55 | 245.81 | 16M | +3.61 |
| Oct 20, 2026 | 226.03 | 243.98 | 216.65 | 242.08 | 17M | +16.05 |
| Oct 19, 2026 | 217.27 | 236.77 | 216.00 | 226.89 | 19M | +9.62 |
| Oct 16, 2026 | 235.00 | 237.96 | 208.92 | 218.01 | 21M | −16.99 |
| Oct 15, 2026 | 225.48 | 242.29 | 217.02 | 236.50 | 17M | +11.02 |
| Oct 14, 2026 | 217.49 | 227.09 | 211.24 | 226.30 | 17M | +8.81 |
| Oct 13, 2026 | 207.63 | 218.48 | 204.70 | 216.25 | 13M | +8.62 |
| Oct 12, 2026 | 224.50 | 227.46 | 210.91 | 213.74 | 13M | −10.76 |
Performance
Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures
1 month return
-3.77%
Change in value over the past month.
3 month return
40.40%
Change in value over the last three months.
Max drawdown
34.16%
Largest fall from a peak to the low that followed.
Standard deviation
204.91%
How far daily returns stray from their average, annualised.
Sharpe ratio
1.59
Return above the risk-free rate per unit of volatility.
Calmar ratio
9.56
Annualised return against the maximum drawdown.
MRNA summary
Loading summary…
MRNA, answered
How does Moderna ensure the safety of its products?
Moderna conducts extensive preclinical and clinical trials to evaluate the safety and efficacy of its products before they reach the market.
How can investors purchase MRNA stock?
Investors can purchase MRNA stock through a brokerage account, similar to any publicly traded stock.
What is the outlook for Moderna’s future growth?
Moderna is well-positioned for growth, given its pioneering role in mRNA technology and ongoing development of new therapies.
Is Moderna publicly traded?
Yes, Moderna is publicly traded on the NASDAQ under the ticker symbol MRNA.
What are the risks of investing in Moderna?
Investing in Moderna involves risks such as regulatory hurdles, competition, and market demand for its products.
How does Moderna address public health needs?
Moderna focuses on developing vaccines and treatments for public health challenges, responding to emerging infectious diseases.
What other therapeutic areas is Moderna exploring?
Moderna is exploring therapies for infectious diseases, cancer, and rare diseases, leveraging its mRNA platform.
What partnerships does Moderna have?
Moderna has established partnerships with various organizations, including government agencies and pharmaceutical companies, to enhance its research and development capabilities.
What is mRNA technology?
mRNA technology uses synthetic messenger RNA to instruct cells to produce proteins that can help prevent or fight diseases.
What is the status of Moderna’s vaccine pipeline?
Moderna has a robust pipeline of mRNA vaccines and therapeutics currently in various stages of clinical trials.
MRNA in the news
Top market assets
Discover our curated selection of top-performing exchange-traded funds (ETFs) that represent a diverse range of investment opportunities.
QQQ is an exchange-traded fund (ETF) that tracks the performance of the Nasdaq-100 Index. This index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market, primarily focusing on technology and innovation sectors.
Metrics and analysis →DIA is an exchange-traded fund (ETF) that aims to track the performance of the Dow Jones Industrial Average (DJIA). The DJIA is a stock market index consisting of 30 large, publicly traded companies in the United States, representing a broad range of industries.
Metrics and analysis →IWM is an exchange-traded fund (ETF) that seeks to track the performance of the Russell 2000 Index. The Russell 2000 Index measures the performance of the 2,000 smallest stocks in the Russell 3000 Index, representing a broad segment of small-cap U.S. companies.
Metrics and analysis →Enhance Your MRNA Trading Now
Empower your trading with OHLCX.com. Our comprehensive platform delivers precise analysis and strategic insights for MRNA, designed to improve your trading outcomes. Boost your investment success with us and unlock new opportunities with our advanced system!
Disclaimers
The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.
With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.
Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.
Securities products are: Not FDIC insured · Not bank guaranteed · May lose value
Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.